|
Class 2 Device Recall |
|
Date Initiated by Firm |
October 25, 2004 |
Date Posted |
November 30, 2004 |
Recall Status1 |
Terminated 3 on February 08, 2006 |
Recall Number |
Z-0260-05 |
Recall Event ID |
30065 |
Product Classification |
Bed, Patient Rotation, Powered - Product Code IKZ
|
Product |
XPRT Therapy Mattress Systems: Model # 2950-000-000 with Dartex urethane-coated nylon cover (deluxe cover); and Model # 2950-000-001 with nylon cover without coating (standard cover). Responsible firm on the label: Manufactured for STRYKER MEDICAL, 6300 South Sprinkle Road, Kalamazoo, MI USA 49001-9799, 1-800-327-0770.
The unit consists of a sleep surface, an integrated valve box located in the head of the mattress, a pump box located under the foot of the mattress and a color touch screen controller that can be mounted to either side of the pump box at the foot end of the mattress. |
Code Information |
The following serial numbers, which represent all units shipped: H40001 thru H40038; and I40001, I40003, I40004, I40005, I40006, I40009, I40012, I40013, I40014, I40017, I40018, and I40021. |
Recalling Firm/ Manufacturer |
Gaymar Industries Inc 10 Centre Dr Orchard Park NY 14127-2280
|
For Additional Information Contact |
Chuck Dunlap 800-828-7341 Ext. 644
|
Manufacturer Reason for Recall |
Design control/validation deficiencies.
|
FDA Determined Cause 2 |
Other |
Action |
Letter dated 10/25/2004 to Stryker Medical, own-label distributor, with instructions to remove patients from the system and return units to Gaymar. |
Quantity in Commerce |
48 units |
Distribution |
The units were sold to the own-label distributor, who in turn sold 8 units to two hospitals in Nebraska and Hawaii. |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|